Autopsy report · NCT03340909

The Norwegian Prednisolone in Early Psychosis Study

“Stopped because of COVID 19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 3 years 11 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Haukeland University Hospital

Sponsor type

University, hospital or other

Conditions

Schizophrenia and Related Disorders; Immune Suppression; Psychosis; Cognitive Change

Interventions

Prednisolone; Placebo

Participants

12

Sites

3

Countries

Norway

Trials that died the same way

• Effect of Artificial Tears on Biometry
  “Stopped due to COVID-19.” (90% match in meaning)
• Transcutaneous Electrical Nerve Stimulation for Local Anaesthesia
  “Stopped early due to COVID19 restrictions” (82% match in meaning)
• RAman For Thyroid cancER
  “Covid19 halted study” (76% match in meaning)
• Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
  “Cancelled due to COVID-19” (75% match in meaning)
• Effects of Exercise and Yogurt on Bone Mineral Density and Immunological Factors in Human Milk: The MEEMA Study
  “COVID 19 pandemic” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.